Background/aim: Even though advanced magnetic resonance imaging (MRI) can effectively differentiate between medulloblastoma and ependymoma, it is not readily available throughout the world. This study aimed to investigate the role of simple quantified basic MRI sequences in the differentiation between medulloblastoma and ependymoma in children.
Patients And Methods: The institutional review board approved this prospective study. The brain MRI protocol, including sagittal T1-weighted, axial T2-weighted, coronal fluid-attenuated inversion recovery, and axial T1-weighted with contrast enhancement (T1WCE) sequences, was assessed in 26 patients divided into two groups: Medulloblastoma (n=22) and ependymoma (n=4). The quantified region of interest (ROI) values of tumors and their ratios to parenchyma were compared between the two groups. Multivariate logistic regression analysis was utilized to find significant factors influencing the differential diagnosis between the two groups. A generalized estimating equation (GEE) was used to create the predictive model for the discrimination of medulloblastoma from ependymoma.
Results: Multivariate logistic regression analysis showed that the T2- and T1WCE-ROI values of tumors and the ratios of T1WCE-ROI values to parenchyma were the most significant factors influencing the diagnosis between these two groups. GEE produced the model: y=e/(1+e) with predictor x=-8.773+0.012x - 0.032x - 13.228x, where x was the T2-weighted signal intensity (SI) of tumor, x the T1WCE SI of tumor, and x the T1WCE SI ratio of tumor to parenchyma. The sensitivity, specificity, and area under the curve of the GEE model were 77.3%, 100%, and 92%, respectively.
Conclusion: The GEE predictive model can discriminate between medulloblastoma and ependymoma clinically. Further research should be performed to validate these findings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.21873/anticanres.14277 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pediatric brain tumor classification using deep learning on MR images with age fusion.
Neurooncol Adv
December 2024
Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden.
Purpose: To implement and evaluate deep learning-based methods for the classification of pediatric brain tumors (PBT) in magnetic resonance (MR) data.
Methods: A subset of the "Children's Brain Tumor Network" dataset was retrospectively used ( = 178 subjects, female = 72, male = 102, NA = 4, age range [0.01, 36.
Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED database.
Neurooncol Adv
October 2024
Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Background: Ependymomas of the spinal cord are rare among children and adolescents, and the individual risk of disease progression is difficult to predict. This study aims to evaluate the prognostic impact of molecular typing on pediatric spinal cord ependymomas.
Methods: Eighty-three patients with spinal ependymomas ≤22 years registered in the HIT-MED database (German brain tumor registry for children, adolescents, and adults with medulloblastoma, ependymoma, pineoblastoma, and CNS-primitive neuroectodermal tumors) between 1992 and 2022 were included.
Diagnostic Utility of Diffusion-Weighted Imaging in Distinguishing Common Pediatric Posterior Fossa Tumors: A Single Center Retrospective Study.
Turk Arch Pediatr
November 2024
Department of Radiology, Adana Dr. Turgut Noyan Application and Research Center, Baskent University Faculty of Medicine, Adana, Türkiye.
Article Synopsis
- Pediatric posterior fossa tumors have complex diagnostic challenges due to their diverse features; this study evaluates the effectiveness of diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) measurements to aid in tumor classification.* -
- The study analyzed 59 patients under 18 with diagnosed posterior fossa tumors, measuring ADC values and ratios from tumor and normal brain tissues, finding significant differences in ADC values between various tumor types (pilocytic astrocytomas, ependymomas, and medulloblastomas).* -
- Results indicate that ADC metrics can effectively differentiate these tumors, though the study suggests that future research should involve larger patient groups and advanced imaging methods to enhance diagnostic accuracy.*
Transcriptomic landscape identifies two unrecognized ependymoma subtypes and novel pathways in medulloblastoma.
bioRxiv
October 2024
Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. 2.
Article Synopsis
- Medulloblastoma and ependymoma are common types of brain tumors in children, and this study analyzes their molecular differences using bulk RNA sequencing data from a large number of tumor samples.
- The researchers processed the data to create a unified landscape, identifying distinct gene expression profiles and molecular characteristics within the tumors, particularly highlighting two compartments in ependymoma and subtypes in medulloblastoma.
- The findings provide a valuable resource for discovering new biomarkers and improving diagnostic accuracy, and the data can be explored using the interactive platform Oncoscape for better patient classification in future research.
Application of radiomics for diagnosis, subtyping, and prognostication of medulloblastomas: a systematic review.
Neurosurg Rev
October 2024
Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Article Synopsis
- * This systematic review followed PRISMA guidelines to analyze 21 studies out of 249 citations screened, highlighting radiomics' potential to differentiate medulloblastomas from other tumors and identify their subtypes.
- * The findings suggest that while radiomics shows promise for predicting survival rates in medulloblastoma patients, further research is needed to fully assess its clinical value.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!